Bosch, F-Xavier; Roura, Esther; de-Sanjose, Silvia; Castellsague, Xavier; Travier, Noemie; Waterboer, Tim; Pawlita, Michael; Pala, Valeria; Gram, Inger-T; Lund, Eiliv; Weiderpass, Elisabete; Margall, Nuria; Dillner, Joakim; Tjonneland, Anne; Munk, Christian; Palli, Domenico; Masala, Giovanna; Khaw, Kay-Tee; Overvad, Kim; Clavel-Chapelon, Franoise; Mesrine, Sylvie; Fournier, Agnes; Fortner, Renee-T; Ose, Jennifer; Steffen, Annika; Trichopoulou, Antonia; Orfanos, Philippos; Lagiou, Pagona; Tumino, Rosario; Sacerdote, Carlotta; Polidoro, Silvia; Mattiello, Amalia; Peeters, Petra-H; Merritt, Melissa-A; Gunter, Marc-J; Riboli, Elio; Bueno-de-Mesquita, H-B(as); Quiros, J-Ramon; Sánchez, María-José; Navarro, Carmen; Barricarte, Aurelio; Larranaga, Nerea; Ekstrom, Johanna; Lindquist, David; Idahl, Annika; Travis, Ruth-C; Rinaldi, Sabina; Tommasino, Massimo; Franceschi, Silvia
(2016-01-25)
BACKGROUND: In addition to HPV, high parity and hormonal contraceptives have been associated with cervical cancer (CC). However, most of the evidence comes from retrospective case-control studies. The aim of this study is ...